Stage IIIB Intraocular Melanoma Recruiting Phase 2 Trials for Valproic acid (DB00313)

IndicationStatusPhase
DBCOND0030839 (Stage IIIB Intraocular Melanoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02068586Adjuvant Sunitinib or Valproic Acid in High-Risk Patients With Uveal MelanomaTreatment